Cargando…
Pulmonary Function and Chest Computed Tomography (CT) Scan Findings After Antifibrotic Treatment for COVID-19-Related Pulmonary Fibrosis
Patient: Female, 51-year-old Final Diagnosis: COVID-19 pneumonia • severe • recovered Symptoms: Cough Medication: — Clinical Procedure: None Specialty: Pulmonology OBJECTIVE: Unusual setting of medical care BACKGROUND: Physicians worldwide have been reporting many cases of COVID-19-induced pulmonary...
Autores principales: | Lomanta, Jan Michael Jesse, Quinto, Milraam L., Urquiza, Sheen C., Santiaguel, Joel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850995/ https://www.ncbi.nlm.nih.gov/pubmed/35152259 http://dx.doi.org/10.12659/AJCR.934830 |
Ejemplares similares
-
ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017) -
Erasmus Syndrome: A Case Report and Literature Review
por: Lomanta, Jan Michael Jesse, et al.
Publicado: (2022) -
Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis
por: Skurikhin, Evgenii, et al.
Publicado: (2020) -
B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic Agents
por: Roman, Jesse, et al.
Publicado: (2021) -
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary
fibrosis
por: Lyu, Xing, et al.
Publicado: (2019)